These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32352884)

  • 1. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
    Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
    JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 3. Palliative Care for Patients With Cancer in the COVID-19 Era.
    Mehta AK; Smith TJ
    JAMA Oncol; 2020 Oct; 6(10):1527-1528. PubMed ID: 32379855
    [No Abstract]   [Full Text] [Related]  

  • 4. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
    Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
    JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
    Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Cruz-Hernández JJ
    JCO Oncol Pract; 2020 Jun; 16(6):348-349. PubMed ID: 32369410
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.
    Dhawan N; Prommer E; Sinclair CT; Subbiah IM
    Curr Treat Options Oncol; 2020 Oct; 21(12):99. PubMed ID: 33119833
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 9. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
    Rubinstein SM; Steinharter JA; Warner J; Rini BI; Peters S; Choueiri TK
    Cancer Cell; 2020 Jun; 37(6):738-741. PubMed ID: 32454025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words".
    Shah UA
    JAMA Oncol; 2020 Sep; 6(9):1330-1331. PubMed ID: 32379856
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice.
    Marandino L; Necchi A; Aglietta M; Di Maio M
    JCO Oncol Pract; 2020 Jun; 16(6):295-298. PubMed ID: 32364846
    [No Abstract]   [Full Text] [Related]  

  • 12. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
    Balogun OD; Bea VJ; Phillips E
    JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic.
    Jan I; Chen K; Sayan M; Uprety P; Laumbach RJ; Ennis RD; Haffty BG
    JAMA Oncol; 2020 Oct; 6(10):1632-1634. PubMed ID: 32852509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with cancer in the COVID-19 era: the clinical trial issue.
    Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
    Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
    Moskowitz CS; Panageas KS
    JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
    [No Abstract]   [Full Text] [Related]  

  • 16. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.
    Wang Z; Wang J; He J
    JAMA Oncol; 2020 May; 6(5):631-632. PubMed ID: 32236504
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Mauri D; Kamposioras K; Tolia M; Alongi F; Tzachanis D;
    Lancet Oncol; 2020 Jun; 21(6):759-760. PubMed ID: 32410877
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
    Garrone O; Denaro N; Ruatta F; Vanella P; Granetto C; Vandone AM; Occelli M; Cauchi C; Ricci V; Fea E; Di Costanzo G; Colantonio I; Crosetto N; Merlano MC
    Tumori; 2020 Oct; 106(5):427-431. PubMed ID: 32703089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
    Yu J; Ouyang W; Chua MLK; Xie C
    JAMA Oncol; 2020 Jul; 6(7):1108-1110. PubMed ID: 32211820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.
    Hofman P; Puchois P; Brest P; Lahlou H; Simeon-Dubach D
    Nat Med; 2020 Jun; 26(6):809-810. PubMed ID: 32382152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.